GCM
STAA icon

Geneva Capital Management’s STAAR Surgical STAA Stock Holding History

Geneva Capital Management’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-662,825
Closed -$16.1M – 130
2024
Q4 		$16.1M Sell
662,825
-32,590
-5% -$931K 0.28% 84
2024
Q3 		$25.8M Buy
695,415
+2,241
+0.3% +$83.6K 0.43% 73
2024
Q2 		$33M Sell
693,174
-18,020
-3% -$790K 0.6% 53
2024
Q1 		$27.2M Sell
711,194
-206,962
-23% -$6.73M 0.48% 69
2023
Q4 		$28.7M Sell
918,156
-35,822
-4% -$1.29M 0.54% 64
2023
Q3 		$38.3M Buy
953,978
+2,949
+0.3% +$138K 0.81% 45
2023
Q2 		$50M Sell
951,029
-6,828
-0.7% -$416K 0.99% 38
2023
Q1 		$61.3M Buy
957,857
+17,400
+2% +$1.14M 1.25% 29
2022
Q4 		$45.6M Sell
940,457
-6,669
-0.7% -$418K 1.03% 37
2022
Q3 		$66.8M Buy
947,126
+38,327
+4% +$3.28M 1.54% 17
2022
Q2 		$64.5M Sell
908,799
-1,078
-0.1% -$69.5K 1.48% 19
2022
Q1 		$72.7M Buy
909,877
+158,452
+21% +$11.8M 1.4% 24
2021
Q4 		$68.6M Buy
751,425
+55,405
+8% +$5.94M 1.11% 33
2021
Q3 		$89.5M Sell
696,020
-125,697
-15% -$17.6M 1.52% 19
2021
Q2 		$125M Sell
821,717
-113,249
-12% -$14.9M 2.04% 6
2021
Q1 		$98.6M Sell
934,966
-348,267
-27% -$34.9M 1.68% 15
2020
Q4 		$102M Sell
1,283,233
-66,878
-5% -$4.89M 1.72% 14
2020
Q3 		$76.4M Buy
1,350,111
+31,581
+2% +$1.7M 1.58% 15
2020
Q2 		$81.1M Buy
1,318,530
+36,728
+3% +$1.5M 1.76% 11
2020
Q1 		$41.4M Buy
+1,281,802
New +$43.2M 1.18% 29

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geneva Capital Management's STAA Position: Q1 2025 in Review

Geneva Capital Management sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 662,825 shares — an estimated $16.1M sold.

Geneva Capital Management first reported a position in STAA in Q1 2020 and held it in 20 quarters. The position peaked at $125M in Q2 2021. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Geneva Capital Management reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Geneva Capital Management sold 662,825 STAAR Surgical shares in Q1 2025, an estimated $16.1M.
  • Geneva Capital Management first reported a position in STAAR Surgical in Q1 2020 and held it in 20 quarters.
  • Geneva Capital Management's STAAR Surgical position peaked at $125M in Q2 2021.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Geneva Capital Management's 13F filing for Q1 2025, filed 9 May 2025.